A Norwegian Swedish clinical trial published in the New England Journal of Medicine (NEJM) demonstrates that rituximab, a low ...
After a median follow-up of 10 years, more than one-third of patients with large B-cell lymphoma and nearly half of patients ...
B-cell lymphoma is a type of non-Hodgkin lymphoma. It’s also the most common type of lymphoma. Approximately 85% of all lymphomas in the United States are B-cell lymphomas. Non-Hodgkin lymphomas are ...
NCCN now recommends pemivibart pre-exposure prophylaxis for patients with B-cell lymphomas and other profoundly ...
Greater understanding of the potential role played by B cells in autoimmune disease has spurred an interest in targeting B cells therapeutically. Greater understanding of the potential role played by ...
Primary mediastinal B-cell lymphoma (PMBCL) is a rare and aggressive type of non-Hodgkin’s lymphoma that originates in the white blood cells behind the breastbone. Although the cause of PMBCL is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results